ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,551Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 537

$872K Total Retail Price of All Prescriptions

Rank: 16 out of 537

586 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 586 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,484 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $126 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SPIRONOLACTONE 1,045 758 10 1 40
LISINOPRIL 596 407 2 3
ATORVASTATIN CALCIUM 377 250 3 26
FUROSEMIDE 363 295 4 2
CALCIUM ACETATE 360 245 10 5 6
AMLODIPINE BESYLATE 337 278 6 1
CLINISOL 315 167 10 7 45
SENSIPAR 283 125 8 5
OMEPRAZOLE 255 165 9 19
CLONIDINE HCL 219 127 10 10
CHLORTHALIDONE 217 191 11 75
NIASPAN 201 102 12 120
METOPROLOL TARTRATE 174 120 13 9
PRAVASTATIN SODIUM 149 101 14 28
SIMVASTATIN 142 115 15 12
NIFEDIPINE ER 132 92 16 16
TORSEMIDE 128 96 17 35
SPIRONOLACTONE-HCTZ 126 118 18 143
ALLOPURINOL 121 88 19 14
LOSARTAN POTASSIUM 121 106 19 15
LEVOTHYROXINE SODIUM 118 75 21 18
LOVAZA 118 64 21 99
NEXIUM 113 69 23 23
PROSOL 111 111 24 17
RENVELA 107 33 25 4
METOPROLOL SUCCINATE 99 82 26 20
DILTIAZEM ER 95 59 27 130
MIRTAZAPINE 93 54 28 114
HYDROCODONE-ACETAMINOPHEN 91 61 S3 29 8
CARVEDILOL 89 62 30 7
CLOPIDOGREL 80 61 31 52
SURE COMFORT 78 40 32 169
LEVOFLOXACIN 76 43 33 60
LIDOCAINE-PRILOCAINE 74 63 34 50
WARFARIN SODIUM 71 48 35 41
DIOVAN 70 48 36 24
CITALOPRAM HBR 69 42 37 68
PLAVIX 65 47 38 64
NIFEDIAC CC 63 57 39 63
ZOLPIDEM TARTRATE 59 16 40 27
CALCITRIOL 57 57 41 13
AZITHROMYCIN 56 26 42 58
LANTUS 50 35 43 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.